NYSE

Inspire Medical Systems, Inc. (INSP)

366 Thanks from members

Inspire Medical Systems (INSP) faces a complex trade-off marked by declining Q2 revenue due to reimbursement and coding disruptions, offset by raised full-year 2026 guidance, margin expansion from the Inspire V mix, and strong cash generation.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →